STAT3 and neoplasm: JAK-STAT signaling is highly active in CSCs, and studies have reported that activation of STAT-3 by IL-6 has a profound effect on tumor initiation and progression, invasion and metastasis by protecting tumor cells from apoptosis, driving epithelial–mesenchymal plasticity, and enhancing angiogenesis (86, 88, 89).